Skip to the page

Data / Drug companies / Marco Pharma International LLC.

Marco Pharma International LLC.: 16 products in the FDA NDC directory, labeler code 60986

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Marco Pharma International LLC. (labeler code 60986) lists 16 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 16 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on February 6, 2025.

The request: Watch Marco Pharma International LLC. (FDA labeler code 60986): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
60986
Products in commercial distribution
16
Packages
25
Finished drugs by generic name
4
Prescription products
0
Over the counter products
16
Flagged as original packager
16 of 16 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
March 1, 1992
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Unapproved homeopathic products16100%

Products by type

TypeProductsShare
Over the counter drugs16100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lithium bromatum12
Sabal serulatum, lycopodium clavatum, pareira brava11
Aconitum napellus, belladonna, chamomilla11
Aconitum napellus, bryonia cretica11

Dosage forms

Dosage formProductsShare
Liquid1381.2%
Tablet, orally disintegrating212.5%
Spray16.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ab60986-2040LiquidUnapproved homeopathic productsFebruary 6, 2025
Polygonum60986-1032LiquidUnapproved homeopathic productsJune 14, 2022
Acusine60986-1040SprayUnapproved homeopathic productsDecember 24, 2021
Abc60986-2035LiquidUnapproved homeopathic productsJanuary 22, 2015
Allernest60986-1003LiquidUnapproved homeopathic productsNovember 18, 2011
Luffa60986-2025Tablet, orally disintegratingUnapproved homeopathic productsMarch 1, 1992
Echinacea60986-2020Tablet, orally disintegratingUnapproved homeopathic productsMarch 1, 1992
Lycopus60986-1030LiquidUnapproved homeopathic productsMarch 1, 1992
Aesculus60986-1027LiquidUnapproved homeopathic productsMarch 1, 1992
Solidago60986-1020LiquidUnapproved homeopathic productsMarch 1, 1992
Lithium60986-1019LiquidUnapproved homeopathic productsMarch 1, 1992
Contessa60986-1014LiquidUnapproved homeopathic productsMarch 1, 1992
Rubus60986-1011LiquidUnapproved homeopathic productsMarch 1, 1992
Sabal Serrulatum60986-1009LiquidUnapproved homeopathic productsMarch 1, 1992
Cholenest60986-1008LiquidUnapproved homeopathic productsMarch 1, 1992
Lymphonest60986-1004LiquidUnapproved homeopathic productsMarch 1, 1992

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.